Multibagger Update: Indrayani Biotech rises 268 per cent in just one year!

Incorporated in 1992, Indrayani Biotech Limited (IBL) is venturing into three verticals namely, food & hospitality, healthcare, and engineering.

On Wednesday, the scrip of Indrayani Biotech surged 3 per cent during the early market hours to record a 52-week high of Rs 41.20 per share on BSE. Its shares have soared 268 per cent in just one year! On a six-month basis, the scrip jumped 70 per cent and furnished returns of nearly 35 per cent since last month.   

The company has recorded net sales and other operating income of Rs 17.25 crore thereby, surging 140.81 per cent from Rs 7.16 crore, registered in Q4FY21. On the other hand, the operating profit was recorded at Rs 2.24 crore in Q4FY22 as compared to an operating loss of Rs 0.42 crore in Q4FY21. Q4FY22 registered a net profit of Rs 1.62 crore in comparison with the net loss of Rs 3.25 crore in the same quarter of the previous year, highlighting a strong profitability position.        

Recently, the company informed the exchange that the company’s two wholly-owned subsidiary companies got converted into public limited. The companies were incorporated as private limited companies with the name ‘IBL Healthcare Private Limited’ & ‘HSL Agri Solutions Private Limited’ on October 30, 2020, and April 5, 2018, respectively.   

Incorporated in 1992, Indrayani Biotech Limited (IBL) is venturing into three verticals namely, food & hospitality, healthcare, and engineering. Keep a close eye on this scrip for the upcoming sessions.